Virax Biolabs Group Limited

Historical 13F Holders

Symbol: VRAX
CUSIP: G9495L125
All holders as of: Q1 2026
Type: Equity
Class: SHS NEW

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G9495L125 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G/A Amendment 1	4.99%	1,000,239	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Armistice Capital, LLC	4.99%	1,000,239
Steven Boyd	4.99%	1,000,239
Armistice Capital, LLC 13G	10.0%	823,909	13G	2/17/2026 Event 12/31/2025
Armistice Capital, LLC	10.0%	823,909
Steven Boyd	10.0%	823,909
Foster James Alexander Cunliffe 13G/A Amendment 3	8.3%	368,570	13G/A Amendment 3	10/29/2025 Event 3/31/2025
Foster James Alexander Cunliffe 13G/A Amendment 2	7.3%	319,945	13G/A Amendment 2	10/29/2025 Event 9/30/2024
Foster James Alexander Cunliffe 13G/A Amendment 1	12.9%	287,987	13G/A Amendment 1	10/29/2025 Event 12/31/2023
Foster James Alexander Cunliffe 13G	24.9%	287,987	13G	10/29/2025 Event 12/31/2022

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q1	3	920 k	$202 k	$0
2025 Q4	5	35.0 k	$12.1 k	$0
2025 Q3	4	94.8 k	$57.0 k	$0
2025 Q2	3	35.2 k	$28.6 k	$0
2025 Q1	5	63.1 k	$71.5 k	$0
2024 Q4	8	63.0 k	$141 k	$0
2024 Q3	6	218 k	$424 k	$0
2024 Q2	8	70.8 k	$81.8 k	$0
2024 Q1	4	17.5 k	$12.5 k	$0
2023 Q4	5	134 k	$195 k	$0